Therefore, α2,6-SIA ratios on IgG-anticyclic citrullinated peptide (CCP) antibodies and IgM-rheumatoid factor (RF) are potential markers for evaluating RA disease activities [27]. The gene discussed is CD40LG; the disease is rheumatoid arthritis.